Rectal neuroendocrine tumors (NETs) are rare, with an incidence of 0.17%, but they
represent 12% to 27% of all NETs and 20% of gastrointestinal NETs. Although rectal NETs …

Rectal neuroendocrine tumors (NETs) account for approximately one-third of all digestive
NETs, with an increasing incidence and good overall prognosis. Although recent guidelines …

Objectives. Endoscopic submucosal dissection (ESD) is a promising technique to treat early
colorectal neoplasms by facilitating en bloc resection without size limitations. Although ESD …

Subepithelial lesions (SEL) of the GI tract represent a mix of benign and potentially
malignant entities including tumors, cysts, or extraluminal structures causing extrinsic …

Background EMR was developed for minimally invasive, organ-sparing endoscopic removal
of benign and early malignant lesions in the GI tract. This report focuses on instruments …

Purpose Endoscopic submucosal dissection (ESD) is a very useful endoscopic technique,
making it possible to perform en bloc resection regardless of lesion size. Since the …

Objective: This study aims to describe recent experience with rectal carcinoids in European
and North American centers. Background: While considered indolent, the propensity of …

Abstract Background and Aim Gastrointestinal carcinoid tumors< 10 mm in diameter and
limited to the submucosal layer demonstrate a low frequency of lymph node and distant …

The estimated annual incidence of R-NENs is 1.04 per 100,000 persons although the real
incidence may be underestimated, as not all R-NEN are systematically reported in registers …

Background While multiple studies have evaluated endoscopic submucosal dissection
(ESD) and transanal endoscopic microsurgery (TEM) to remove large rectal tumors, there …